Medical Aesthetics Market - Distribution by Type of Product and / or Device Offered (Botox, Dermal Fillers, Chemical Peels, Body Contouring, Gluteal Implants, Hair Removal, Breast Implants and Other Products and / or Devices), Type of Procedure (Non Invasive, Minimally Invasive and Invasive), End User (Hospitals, Clinics / Med Spas and Dermatology / Cosmetology Centers, and Other end users), Gender (Male and Female), Distribution Channel (Direct Distribution and Indirect Distribution), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts
The medical aesthetics market is expected to reach USD 32 billion by 2023 anticipated to grow at a CAGR of 9.6% during the forecast period 2023-2035.
The demand for medical aesthetic solutions has surged in recent years due to various factors, including the desire to maintain a youthful appearance, the influence of social media, technological advancements, celebrity endorsements, and the support of beauticians and medical professionals. The COVID-19 pandemic has also contributed significantly to the increased demand for aesthetic treatments. According to the American Academy of Facial Plastic and Reconstructive Surgery, the pandemic has led to a 10% increase in the number of cosmetic surgeries. Medical aesthetics is a well-established branch of modern medicine that primarily focuses on enhancing an individual's cosmetic appearance without clinical surgery, primarily for anti-aging purposes, such as reducing fine lines, wrinkles, and skin rejuvenation. Additionally, these procedures can help reduce excess fat, cellulite, unwanted hair, and spider veins. According to a study by the International Society of Aesthetic Plastic Surgery (ISAPS), over 15 million invasive and 19 million non-invasive aesthetic procedures were performed globally in 2022, with nearly 90% of the clientele being women, although these procedures are also gaining popularity among men. The global medical aesthetics market is expected to grow at a CAGR of 10.41% from 2023 to 2032, primarily driven by the increasing demand for non-invasive cosmetic procedures, technological advancements, and a growing aging population. The rise in the male aesthetic market is evident, with more men opting for aesthetic and cosmetic treatments, such as rhinoplasty, eyelid surgery, and liposuction. The COVID-19 pandemic has significantly impacted the medical aesthetics market, with reduced discretionary spending, a shift in consumer priorities, and reduced disposable income affecting the demand for medical aesthetics. However, medical aesthetic practitioners are adapting their marketing strategies, offering competitive pricing, and emphasizing the long-term benefits of aesthetic interventions to attract and retain customers.
The increasing popularity and high adoption rates of these procedures has led medical aesthetics companies to develop medical aesthetics products and devices focusing on non-surgical or minimally invasive solutions. These procedures usually do not require a full-on surgical procedure, resulting in less pain, less discomfort, less risks and shorter hospital stays, and long-term results. Some of the most popular minimally invasive procedures include botulinum toxin, aesthetic fillers, and body contouring devices used to tighten the skin, reduce fat, and reduce cellulite. It is important to note that the advantages of aesthetic procedures go beyond cosmetic appearance, as they can also help with other commonly reported healthcare issues. For example, botulinum toxin can help to reduce sweating, migraines, and other conditions.
Medical aesthetic treatments can be carried out at medical aesthetics clinics as well as at a medical spa by various medical professionals such as dermatologist, plastic surgeon, doctor, nurse practitioner, registered nurse and aesthetician. Interestingly, more than 70 percent of the current market for medical aesthetics is concentrated in hospitals, clinics & medical spas. South Korea, which is the cosmetic surgery capital of the world, has the highest number of cosmetic surgeries per capita in the world. This is due to the well-established cosmetic surgery infrastructure and experienced medical professionals that promote aesthetics medical tourism in South Korea. However, there is a concern that medical aesthetic treatments may violate the regulatory guidelines by some medical professionals & medical aesthetics companies which may lead to side effects. Hence, it is very important that the patient undergoes treatment by the licensed medical professional with certified aesthetic devices in order to avoid any possible risks & complications. Overcoming these challenges and meeting the growing demand for medical aesthetics procedures, the market of medical aesthetics companies is expected to experience significant growth over the next few years.
Report Coverage
The demand for medical aesthetic solutions has surged in recent years due to various factors, including the desire to maintain a youthful appearance, the influence of social media, technological advancements, celebrity endorsements, and the support of beauticians and medical professionals. The COVID-19 pandemic has also contributed significantly to the increased demand for aesthetic treatments. According to the American Academy of Facial Plastic and Reconstructive Surgery, the pandemic has led to a 10% increase in the number of cosmetic surgeries. Medical aesthetics is a well-established branch of modern medicine that primarily focuses on enhancing an individual's cosmetic appearance without clinical surgery, primarily for anti-aging purposes, such as reducing fine lines, wrinkles, and skin rejuvenation. Additionally, these procedures can help reduce excess fat, cellulite, unwanted hair, and spider veins. According to a study by the International Society of Aesthetic Plastic Surgery (ISAPS), over 15 million invasive and 19 million non-invasive aesthetic procedures were performed globally in 2022, with nearly 90% of the clientele being women, although these procedures are also gaining popularity among men. The global medical aesthetics market is expected to grow at a CAGR of 10.41% from 2023 to 2032, primarily driven by the increasing demand for non-invasive cosmetic procedures, technological advancements, and a growing aging population. The rise in the male aesthetic market is evident, with more men opting for aesthetic and cosmetic treatments, such as rhinoplasty, eyelid surgery, and liposuction. The COVID-19 pandemic has significantly impacted the medical aesthetics market, with reduced discretionary spending, a shift in consumer priorities, and reduced disposable income affecting the demand for medical aesthetics. However, medical aesthetic practitioners are adapting their marketing strategies, offering competitive pricing, and emphasizing the long-term benefits of aesthetic interventions to attract and retain customers.
The increasing popularity and high adoption rates of these procedures has led medical aesthetics companies to develop medical aesthetics products and devices focusing on non-surgical or minimally invasive solutions. These procedures usually do not require a full-on surgical procedure, resulting in less pain, less discomfort, less risks and shorter hospital stays, and long-term results. Some of the most popular minimally invasive procedures include botulinum toxin, aesthetic fillers, and body contouring devices used to tighten the skin, reduce fat, and reduce cellulite. It is important to note that the advantages of aesthetic procedures go beyond cosmetic appearance, as they can also help with other commonly reported healthcare issues. For example, botulinum toxin can help to reduce sweating, migraines, and other conditions.
Medical aesthetic treatments can be carried out at medical aesthetics clinics as well as at a medical spa by various medical professionals such as dermatologist, plastic surgeon, doctor, nurse practitioner, registered nurse and aesthetician. Interestingly, more than 70 percent of the current market for medical aesthetics is concentrated in hospitals, clinics & medical spas. South Korea, which is the cosmetic surgery capital of the world, has the highest number of cosmetic surgeries per capita in the world. This is due to the well-established cosmetic surgery infrastructure and experienced medical professionals that promote aesthetics medical tourism in South Korea. However, there is a concern that medical aesthetic treatments may violate the regulatory guidelines by some medical professionals & medical aesthetics companies which may lead to side effects. Hence, it is very important that the patient undergoes treatment by the licensed medical professional with certified aesthetic devices in order to avoid any possible risks & complications. Overcoming these challenges and meeting the growing demand for medical aesthetics procedures, the market of medical aesthetics companies is expected to experience significant growth over the next few years.
Report Coverage
- The report comprehensively examines the medical aesthetics market across various parameters, including type of product and / or device offered, type of procedure, end user, gender, distribution channel, and key geographical regions.
- It thoroughly analyzes market influences such as drivers, restraints, opportunities, and challenges, while evaluating competitive landscapes for top players. Forecasts are provided for segment revenues across major regions.
- This report covers the evolution of medical aesthetics, types, application areas, benefits over traditional beauty treatments, and side effects. Further, it also features key growth drivers, emerging technologies, key challenges, and future opportunities.
- A detailed analysis of medical aesthetics developers covers aspects such as establishment year, company size, headquarters, type of offering (product and / or device), type of products and / or devices offered, application area, type of procedure and end user.
- The report presents comprehensive profiles of leading medical aesthetics developers, detailing company overviews, financial information (where available), offered medical aesthetic procedures, recent developments, and future outlooks.
- Further, the report evaluates medical aesthetics company competitiveness, considering supplier strength in terms of type of offering, type of product and / or device offered and type of procedure, and number of end users served.
- Examination of collaborations and partnerships formed by players in medical aesthetics market since 2018 encompassing areas such as merger and acquisition, distribution, commercialization, licensing, supply, product development, product and technology integration and manufacturing agreements.
- Analysis of funding and investments in medical aesthetics market from 2018 to 2023 covers funding timelines, types, key players, and primary investors based on investment amounts and funding instances.
- ADSS
- Allergan Aesthetics
- Astiland, Beijing Kes Biological Technology
- BTL Aesthetics
- Candela Medical
- Classys
- Croma Pharma
- Cynosure
- Daeyang Medical
- Establishment Labs
- Galderma
- Guangzhou Itech Aesthetics
- IBSA
- Lumenis
- Lutronic
- MedicalZone
- Mentor
- Sanhe Medical
- Shanghai Haohai Biological Technology
- Sinclair Pharma
- Sincoheren
- Skin Tech Pharma
- Wontech
- Zesay Beauty
1. PREFACE
1.1. Introduction
1.2. Project Objectives
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Concept of Medical Aesthetics
5.3. Evolution of Medical Aesthetics
5.4. Types of Medical Aesthetic Procedures
5.4.1. Non-invasive Procedures
5.4.1.1. Facial Aesthetics
5.4.1.1.1. Botulinum Toxin
5.4.1.1.2. Dermal Fillers
5.4.1.1.3. Chemical Peels
5.4.1.1.4. Microdermabrasion
5.4.1.1.5. Microneedling
5.4.1.1.6. Thread Lift
5.4.1.2. Body Contouring
5.4.1.3. Hair Removal
5.4.1.3.1. Intense Pulse Light Hair Removal
5.4.1.3.2. Laser Hair Removal
5.4.1.4. Tattoo Removal
5.4.1.5. Nail Treatment
5.4.1.6. Eyelash Treatment
5.4.1.7. Permanent Make-up
5.4.2. Invasive Procedures
5.4.2.1. Breast Surgery
5.4.2.2. Gluteal Implants
5.4.2.3. Facial Surgery
5.4.2.4. Liposuction
5.4.2.5. Cosmetic Gynecology
5.5. Advantages of Medical Aesthetics
5.6. Side Effects of Medical Aesthetics
5.7. Key Growth Drivers
5.8. Emerging Technologies in Medical Aesthetics
5.8.1. Virtual Reality in Medical Aesthetics
5.8.2. Augmented Reality in Medical Aesthetics
5.8.3. Artificial Intelligence in Medical Aesthetics
5.8.4. Telemedicine in Medical Aesthetics
5.9. Key Challenges of Medical Aesthetics
5.10. Future Perspectives
6. MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Medical Aesthetic Companies: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Location of Headquarters (Region)
6.2.4. Analysis by Location of Headquarters (Country)
6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
6.2.6. Analysis by Company Size and Location of Headquarters (Region)
6.2.7. Analysis by Type of Offering
6.2.8. Analysis by Type of Products and / or Devices Offered
6.2.9. Analysis by Type of Facial Aesthetic Products and / or Devices Offered
6.2.10. Analysis by Type of Body Contouring Products and / or Devices Offered
6.2.11. Analysis by Type of Hair Removal Devices Offered
6.2.12. Analysis by Type of Breast Aesthetic Products and / or Devices Offered
6.2.13. Analysis by Application Area
6.2.14. Analysis by Type of Procedure
6.2.15. Analysis by End-user
6.2.16. Analysis by Type of Products and / or Devices Offered and Location of Headquarters (Region)
6.2.17. Analysis by Type of Procedure and Location of Headquarters (Region)
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Detailed Company Profiles of Key Players
7.2.1. Companies Headquartered in North America
7.2.1.1. Allergan Aesthetics
7.2.1.1.1. Company Overview
7.2.1.1.2. Financial Information
7.2.1.1.3. Medical Aesthetics Portfolio
7.2.1.1.4. Recent Developments and Future Outlook
7.2.1.2. Candela Medical
7.2.1.2.1. Company Overview
7.2.1.2.2. Medical Aesthetics Portfolio
7.2.1.2.3. Recent Developments and Future Outlook
7.2.1.3. Cynosure
7.2.1.3.1. Company Overview
7.2.1.3.2. Medical Aesthetics Portfolio
7.2.1.3.3. Recent Developments and Future Outlook
7.2.1.4. Lutronic
7.2.1.4.1. Company Overview
7.2.1.4.2. Medical Aesthetics Portfolio
7.2.1.4.3. Recent Developments and Future Outlook
7.2.1.5. Mentor
7.2.1.5.1. Company Overview
7.2.1.5.2. Medical Aesthetics Portfolio
7.2.1.5.3. Recent Developments and Future Outlook
7.2.2. Companies Headquartered in Europe
7.2.2.1. BTL Aesthetics
7.2.2.1.1. Company Overview
7.2.2.1.2. Medical Aesthetics Portfolio
7.2.2.1.3. Recent Developments and Future Outlook
7.2.2.2. Croma Pharma
7.2.2.2.1. Company Overview
7.2.2.2.2. Financial Information
7.2.2.2.3. Medical Aesthetics Portfolio
7.2.2.2.4. Recent Developments and Future Outlook
7.2.2.3. Galderma
7.2.2.3.1. Company Overview
7.2.2.3.2. Financial Information
7.2.2.3.3. Medical Aesthetics Portfolio
7.2.2.3.4. Recent Developments and Future Outlook
7.2.2.4. IBSA
7.2.2.4.1. Company Overview
7.2.2.4.2. Medical Aesthetics Portfolio
7.2.2.4.3. Recent Developments and Future Outlook
7.2.2.5. Sinclair Pharma
7.2.2.5.1. Company Overview
7.2.2.5.2. Medical Aesthetics Portfolio
7.2.2.5.3. Recent Developments and Future Outlook
7.2.3. Companies Headquartered in Asia-Pacific and Rest of the World
7.2.3.1. Classys
7.2.3.1.1. Company Overview
7.2.3.1.2. Financial Information
7.2.3.1.3. Medical Aesthetics Portfolio
7.2.3.1.4. Recent Developments and Future Outlook
7.2.3.2. Daeyang Medical
7.2.3.2.1. Company Overview
7.2.3.2.2. Medical Aesthetics Portfolio
7.2.3.2.3. Recent Developments and Future Outlook
7.2.3.3. Establishment Labs
7.2.3.3.1. Company Overview
7.2.3.3.2. Financial Information
7.2.3.3.3. Medical Aesthetics Portfolio
7.2.3.3.4. Recent Developments and Future Outlook
7.2.3.4. Lumenis
7.2.3.4.1. Company Overview
7.2.3.4.2. Medical Aesthetics Portfolio
7.2.3.4.3. Recent Developments and Future Outlook
7.2.3.5. Shanghai Haohai Biological Technology
7.2.3.5.1. Company Overview
7.2.3.5.2. Financial Information
7.2.3.5.3. Medical Aesthetics Portfolio
7.2.3.5.4. Recent Developments and Future Outlook
7.3. Short Profiles of Other Prominent Players
7.3.1. ADSS
7.3.1.1. Company Overview
7.3.1.2. Medical Aesthetics Portfolio
7.3.2. Astiland
7.3.2.1. Company Overview
7.3.2.2. Medical Aesthetics Portfolio
7.3.3. Beijing Kes Biological Technology
7.3.3.1. Company Overview
7.3.3.2. Medical Aesthetics Portfolio
7.3.4. Guangzhou Itech Aesthetics 7.3.4.1.Company Overview
7.3.4.2. Medical Aesthetics Portfolio
7.3.5. MedicalZone
7.3.5.1. Company Overview
7.3.5.2. Medical Aesthetics Portfolio
7.3.6. Sanhe Medical
7.3.6.1. Company Overview
7.3.6.2. Medical Aesthetics Portfolio
7.3.7. Sincoheren
7.3.7.1. Company Overview
7.3.7.2. Medical Aesthetics Portfolio
7.3.8. Skin Tech Pharma
7.3.8.1. Company Overview
7.3.8.2. Medical Aesthetics Portfolio
7.3.9. Wontech
7.3.9.1. Company Overview
7.3.9.2. Medical Aesthetics Portfolio
7.3.10. Zesay Beauty
7.3.10.1. Company Overview
7.3.10.2. Medical Aesthetics Portfolio
8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Key Assumptions and Parameters
8.3. Methodology
8.4. Medical Aesthetics: Company Competitiveness Analysis
8.4.1. Companies based in North America
8.4.2. Companies based in Europe
8.4.3 Companies based in Asia-Pacific and Rest of the World
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Medical Aesthetics: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Focus Area
9.3.5. Most Active Players: Analysis by Number of Partnerships
9.4. Analysis by Geography
9.4.1. Local and International Agreements
9.4.2. Intracontinental and Intercontinental Agreements
10. FUNDING AND INVESTMENTS
10.1. Chapter Overview
10.2. Funding Models
10.3. Medical Aesthetics: Funding and Investments
10.3.1. Analysis by Year of Funding
10.3.2. Analysis by Amount Invested
10.3.3. Analysis by Type of Funding
10.3.4. Analysis by Year and Type of Funding
10.3.5. Analysis by Type of Funding and Amount Invested
10.3.6. Analysis by Geography
10.3.7. Most Active Players
10.3.7.1. Analysis by Number of Funding Instances
10.3.7.2. Analysis by Amount Raised
10.3.8. Leading Investors: Analysis by Number of Funding Instances
10.3.9. Analysis by Company Size and Amount Invested
10.4. Concluding Remarks
11. DELT ANALYSIS
11.1. Chapter Overview
11.2. Methodology
11.3. Key Parameters
11.3.1. Demographical Factors
11.3.2. Environmental Factors
11.3.3. Legal Factors
11.3.4. Technological Factors
11.4. Medical Aesthetics: DELT Analysis
11.4.1. Allergan Aesthetics
11.4.2. Candela
11.4.3. Cutera
11.4.4. Biotechitalia
11.4.5. Sinclair Pharma
11.4.6. Merz Pharma
11.4.7. Dermosistemi
11.4.8. Alma Lasers
11.4.9. Bison Medical
11.5. Conclusion
12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion
13. GLOBAL MEDICAL AESTHETICS MARKET
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Global Medical Aesthetics Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
13.3.1. Scenario Analysis
13.3.1.1. Conservative Scenario Analysis
13.3.1.2. Optimistic Scenario Analysis
13.4. Key Market Segmentations
13.5. Dynamic Dashboards
14. MEDICAL AESTHETICS MARKET, BY TYPE OF PRODUCT AND / OR DEVICE OFFERED
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered, 2018, 2023 and 2035
14.3.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.4. Body Contouring: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.5. Hair Removal: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.6. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.7. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.8. Other Products and / or Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.4. Data Triangulation and Validation
15. MEDICAL AESTHETICS MARKET, BY TYPE OF PROCEDURE
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Medical Aesthetics Market: Distribution by Type of Procedure, 2018, 2023 and 2035
15.3.1. Non-invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.3.2. Minimally Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.3.3. Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.4. Data Triangulation and Validation
16. MEDICAL AESTHETICS MARKET, BY END-USER
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Medical Aesthetics Market: Distribution by End-user, 2018, 2023 and 2035
16.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Data Triangulation and Validation
17. MEDICAL AESTHETICS MARKET, BY GENDER
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Medical Aesthetics Market: Distribution by Gender, 2018, 2023 and 2035
17.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4. Data Triangulation and Validation
18. MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Medical Aesthetics Market, by Distribution Channel, 2018, 2023 and 2035
18.3.1. Direct Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.3.2. Indirect Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.4. Data Triangulation and Validation
19. MEDICAL AESTEHTICS MARKET, BY KEY GEOGRAPHICAL REGION
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Medical Aesthetics Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035
19.3.1. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.1.1. US: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.1.2. Canada: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.1.3. Mexico: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.1. UK: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.2. Germany: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.3. France: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.4. Italy: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.5. Spain: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.5. Rest of the Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.1. China: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.2. South Korea Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.3. Japan: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.4. India: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4. Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4.1. Turkey: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4.2. Iran: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5.1. Brazil: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5.2. Argentina: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5.3. Rest of the Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.4. Data Triangulation and Validation
20. MEDICAL AESTHETICS PRODUCTS MARKET
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Global Medical Aesthetics Products Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1. Medical Aesthetics Products Market, by Type of Product Offered, 2018, 2023 and 2035
20.3.1.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.4. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.5. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1. Medical Aesthetics Products Market, by Key Geographical Regions, 2018, 2023 and 2035
20.4.1.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.5. Data Triangulation and Validation
21. EXECUTIVE INSIGHTS
22. CONCLUSION
23. APPENDIX 1: TABULATED DATA
24. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
1.1. Introduction
1.2. Project Objectives
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Concept of Medical Aesthetics
5.3. Evolution of Medical Aesthetics
5.4. Types of Medical Aesthetic Procedures
5.4.1. Non-invasive Procedures
5.4.1.1. Facial Aesthetics
5.4.1.1.1. Botulinum Toxin
5.4.1.1.2. Dermal Fillers
5.4.1.1.3. Chemical Peels
5.4.1.1.4. Microdermabrasion
5.4.1.1.5. Microneedling
5.4.1.1.6. Thread Lift
5.4.1.2. Body Contouring
5.4.1.3. Hair Removal
5.4.1.3.1. Intense Pulse Light Hair Removal
5.4.1.3.2. Laser Hair Removal
5.4.1.4. Tattoo Removal
5.4.1.5. Nail Treatment
5.4.1.6. Eyelash Treatment
5.4.1.7. Permanent Make-up
5.4.2. Invasive Procedures
5.4.2.1. Breast Surgery
5.4.2.2. Gluteal Implants
5.4.2.3. Facial Surgery
5.4.2.4. Liposuction
5.4.2.5. Cosmetic Gynecology
5.5. Advantages of Medical Aesthetics
5.6. Side Effects of Medical Aesthetics
5.7. Key Growth Drivers
5.8. Emerging Technologies in Medical Aesthetics
5.8.1. Virtual Reality in Medical Aesthetics
5.8.2. Augmented Reality in Medical Aesthetics
5.8.3. Artificial Intelligence in Medical Aesthetics
5.8.4. Telemedicine in Medical Aesthetics
5.9. Key Challenges of Medical Aesthetics
5.10. Future Perspectives
6. MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Medical Aesthetic Companies: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Location of Headquarters (Region)
6.2.4. Analysis by Location of Headquarters (Country)
6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
6.2.6. Analysis by Company Size and Location of Headquarters (Region)
6.2.7. Analysis by Type of Offering
6.2.8. Analysis by Type of Products and / or Devices Offered
6.2.9. Analysis by Type of Facial Aesthetic Products and / or Devices Offered
6.2.10. Analysis by Type of Body Contouring Products and / or Devices Offered
6.2.11. Analysis by Type of Hair Removal Devices Offered
6.2.12. Analysis by Type of Breast Aesthetic Products and / or Devices Offered
6.2.13. Analysis by Application Area
6.2.14. Analysis by Type of Procedure
6.2.15. Analysis by End-user
6.2.16. Analysis by Type of Products and / or Devices Offered and Location of Headquarters (Region)
6.2.17. Analysis by Type of Procedure and Location of Headquarters (Region)
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Detailed Company Profiles of Key Players
7.2.1. Companies Headquartered in North America
7.2.1.1. Allergan Aesthetics
7.2.1.1.1. Company Overview
7.2.1.1.2. Financial Information
7.2.1.1.3. Medical Aesthetics Portfolio
7.2.1.1.4. Recent Developments and Future Outlook
7.2.1.2. Candela Medical
7.2.1.2.1. Company Overview
7.2.1.2.2. Medical Aesthetics Portfolio
7.2.1.2.3. Recent Developments and Future Outlook
7.2.1.3. Cynosure
7.2.1.3.1. Company Overview
7.2.1.3.2. Medical Aesthetics Portfolio
7.2.1.3.3. Recent Developments and Future Outlook
7.2.1.4. Lutronic
7.2.1.4.1. Company Overview
7.2.1.4.2. Medical Aesthetics Portfolio
7.2.1.4.3. Recent Developments and Future Outlook
7.2.1.5. Mentor
7.2.1.5.1. Company Overview
7.2.1.5.2. Medical Aesthetics Portfolio
7.2.1.5.3. Recent Developments and Future Outlook
7.2.2. Companies Headquartered in Europe
7.2.2.1. BTL Aesthetics
7.2.2.1.1. Company Overview
7.2.2.1.2. Medical Aesthetics Portfolio
7.2.2.1.3. Recent Developments and Future Outlook
7.2.2.2. Croma Pharma
7.2.2.2.1. Company Overview
7.2.2.2.2. Financial Information
7.2.2.2.3. Medical Aesthetics Portfolio
7.2.2.2.4. Recent Developments and Future Outlook
7.2.2.3. Galderma
7.2.2.3.1. Company Overview
7.2.2.3.2. Financial Information
7.2.2.3.3. Medical Aesthetics Portfolio
7.2.2.3.4. Recent Developments and Future Outlook
7.2.2.4. IBSA
7.2.2.4.1. Company Overview
7.2.2.4.2. Medical Aesthetics Portfolio
7.2.2.4.3. Recent Developments and Future Outlook
7.2.2.5. Sinclair Pharma
7.2.2.5.1. Company Overview
7.2.2.5.2. Medical Aesthetics Portfolio
7.2.2.5.3. Recent Developments and Future Outlook
7.2.3. Companies Headquartered in Asia-Pacific and Rest of the World
7.2.3.1. Classys
7.2.3.1.1. Company Overview
7.2.3.1.2. Financial Information
7.2.3.1.3. Medical Aesthetics Portfolio
7.2.3.1.4. Recent Developments and Future Outlook
7.2.3.2. Daeyang Medical
7.2.3.2.1. Company Overview
7.2.3.2.2. Medical Aesthetics Portfolio
7.2.3.2.3. Recent Developments and Future Outlook
7.2.3.3. Establishment Labs
7.2.3.3.1. Company Overview
7.2.3.3.2. Financial Information
7.2.3.3.3. Medical Aesthetics Portfolio
7.2.3.3.4. Recent Developments and Future Outlook
7.2.3.4. Lumenis
7.2.3.4.1. Company Overview
7.2.3.4.2. Medical Aesthetics Portfolio
7.2.3.4.3. Recent Developments and Future Outlook
7.2.3.5. Shanghai Haohai Biological Technology
7.2.3.5.1. Company Overview
7.2.3.5.2. Financial Information
7.2.3.5.3. Medical Aesthetics Portfolio
7.2.3.5.4. Recent Developments and Future Outlook
7.3. Short Profiles of Other Prominent Players
7.3.1. ADSS
7.3.1.1. Company Overview
7.3.1.2. Medical Aesthetics Portfolio
7.3.2. Astiland
7.3.2.1. Company Overview
7.3.2.2. Medical Aesthetics Portfolio
7.3.3. Beijing Kes Biological Technology
7.3.3.1. Company Overview
7.3.3.2. Medical Aesthetics Portfolio
7.3.4. Guangzhou Itech Aesthetics 7.3.4.1.Company Overview
7.3.4.2. Medical Aesthetics Portfolio
7.3.5. MedicalZone
7.3.5.1. Company Overview
7.3.5.2. Medical Aesthetics Portfolio
7.3.6. Sanhe Medical
7.3.6.1. Company Overview
7.3.6.2. Medical Aesthetics Portfolio
7.3.7. Sincoheren
7.3.7.1. Company Overview
7.3.7.2. Medical Aesthetics Portfolio
7.3.8. Skin Tech Pharma
7.3.8.1. Company Overview
7.3.8.2. Medical Aesthetics Portfolio
7.3.9. Wontech
7.3.9.1. Company Overview
7.3.9.2. Medical Aesthetics Portfolio
7.3.10. Zesay Beauty
7.3.10.1. Company Overview
7.3.10.2. Medical Aesthetics Portfolio
8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Key Assumptions and Parameters
8.3. Methodology
8.4. Medical Aesthetics: Company Competitiveness Analysis
8.4.1. Companies based in North America
8.4.2. Companies based in Europe
8.4.3 Companies based in Asia-Pacific and Rest of the World
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Medical Aesthetics: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Focus Area
9.3.5. Most Active Players: Analysis by Number of Partnerships
9.4. Analysis by Geography
9.4.1. Local and International Agreements
9.4.2. Intracontinental and Intercontinental Agreements
10. FUNDING AND INVESTMENTS
10.1. Chapter Overview
10.2. Funding Models
10.3. Medical Aesthetics: Funding and Investments
10.3.1. Analysis by Year of Funding
10.3.2. Analysis by Amount Invested
10.3.3. Analysis by Type of Funding
10.3.4. Analysis by Year and Type of Funding
10.3.5. Analysis by Type of Funding and Amount Invested
10.3.6. Analysis by Geography
10.3.7. Most Active Players
10.3.7.1. Analysis by Number of Funding Instances
10.3.7.2. Analysis by Amount Raised
10.3.8. Leading Investors: Analysis by Number of Funding Instances
10.3.9. Analysis by Company Size and Amount Invested
10.4. Concluding Remarks
11. DELT ANALYSIS
11.1. Chapter Overview
11.2. Methodology
11.3. Key Parameters
11.3.1. Demographical Factors
11.3.2. Environmental Factors
11.3.3. Legal Factors
11.3.4. Technological Factors
11.4. Medical Aesthetics: DELT Analysis
11.4.1. Allergan Aesthetics
11.4.2. Candela
11.4.3. Cutera
11.4.4. Biotechitalia
11.4.5. Sinclair Pharma
11.4.6. Merz Pharma
11.4.7. Dermosistemi
11.4.8. Alma Lasers
11.4.9. Bison Medical
11.5. Conclusion
12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion
13. GLOBAL MEDICAL AESTHETICS MARKET
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Global Medical Aesthetics Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
13.3.1. Scenario Analysis
13.3.1.1. Conservative Scenario Analysis
13.3.1.2. Optimistic Scenario Analysis
13.4. Key Market Segmentations
13.5. Dynamic Dashboards
14. MEDICAL AESTHETICS MARKET, BY TYPE OF PRODUCT AND / OR DEVICE OFFERED
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered, 2018, 2023 and 2035
14.3.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.4. Body Contouring: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.5. Hair Removal: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.6. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.7. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.8. Other Products and / or Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.4. Data Triangulation and Validation
15. MEDICAL AESTHETICS MARKET, BY TYPE OF PROCEDURE
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Medical Aesthetics Market: Distribution by Type of Procedure, 2018, 2023 and 2035
15.3.1. Non-invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.3.2. Minimally Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.3.3. Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.4. Data Triangulation and Validation
16. MEDICAL AESTHETICS MARKET, BY END-USER
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Medical Aesthetics Market: Distribution by End-user, 2018, 2023 and 2035
16.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Data Triangulation and Validation
17. MEDICAL AESTHETICS MARKET, BY GENDER
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Medical Aesthetics Market: Distribution by Gender, 2018, 2023 and 2035
17.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4. Data Triangulation and Validation
18. MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Medical Aesthetics Market, by Distribution Channel, 2018, 2023 and 2035
18.3.1. Direct Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.3.2. Indirect Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.4. Data Triangulation and Validation
19. MEDICAL AESTEHTICS MARKET, BY KEY GEOGRAPHICAL REGION
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Medical Aesthetics Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035
19.3.1. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.1.1. US: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.1.2. Canada: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.1.3. Mexico: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.1. UK: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.2. Germany: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.3. France: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.4. Italy: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.5. Spain: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.5. Rest of the Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.1. China: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.2. South Korea Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.3. Japan: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.4. India: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4. Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4.1. Turkey: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4.2. Iran: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5.1. Brazil: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5.2. Argentina: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5.3. Rest of the Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.4. Data Triangulation and Validation
20. MEDICAL AESTHETICS PRODUCTS MARKET
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Global Medical Aesthetics Products Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1. Medical Aesthetics Products Market, by Type of Product Offered, 2018, 2023 and 2035
20.3.1.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.4. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.5. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1. Medical Aesthetics Products Market, by Key Geographical Regions, 2018, 2023 and 2035
20.4.1.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.5. Data Triangulation and Validation
21. EXECUTIVE INSIGHTS
22. CONCLUSION
23. APPENDIX 1: TABULATED DATA
24. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
